CJEU Confirms Settlements Can Break EU Law
In Ruling Related To ‘Pay For Delay’ Deals Over Paroxetine
The UK’s Competition and Markets Authority has welcomed a formal ruling by the CJEU that settling patent disputes can break EU law by restricting competition and abusing a dominant position, in a case revolving around so-called ‘pay for delay’ settlements over GSK’s Seroxat paroxetine antidepressant.
